S, R., F, S., G, G., F, D. G., & A, R. (2026). Is the unavailability of rifapentine holding back the end TB strategy in Europe? Implication for tuberculosis control among migrants and refugees. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 45(4), 1221. https://doi.org/10.1007/s10096-025-05304-4
Chicago Style (17th ed.) CitationS, Rotundo, Serapide F, Guido G, Di Gennaro F, and Russo A. "Is the Unavailability of Rifapentine Holding Back the End TB Strategy in Europe? Implication for Tuberculosis Control Among Migrants and Refugees." European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology 45, no. 4 (2026): 1221. https://doi.org/10.1007/s10096-025-05304-4.
MLA (9th ed.) CitationS, Rotundo, et al. "Is the Unavailability of Rifapentine Holding Back the End TB Strategy in Europe? Implication for Tuberculosis Control Among Migrants and Refugees." European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology, vol. 45, no. 4, 2026, p. 1221, https://doi.org/10.1007/s10096-025-05304-4.
